GE HealthCare Technologies Inc. Common Stock vs McCormick & Company, Incorporated — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $70.77 (market cap $30.93B), while McCormick & Company, Incorporated trades at $46.42 (market cap $12.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2.6× McCormick & Company, Incorporated's market cap, and McCormick & Company, Incorporated pays the higher dividend (4.29%). Which is the better fit depends on your goals.
| GEHC | MKC | |
|---|---|---|
Market Cap | $30.93B | $12.07B |
Volume | 5,033,451 | 3,953,478 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $71.65 |
52-Week Low | $59.48 | $44.14 |
Enterprise Value | $39.39B | $16.76B |
Dividend Yield | 0.23% | 4.29% |
Typical Hold Time | — | 68 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
McCormick & Company (MKC) trades at $44.64, down 2.06% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q3 2026 earnings of $0.86 per share, beating estimates, driven by 17% sales growth including contributions from the Mexico acquisition. Valuation metrics appear attractive with a P/E of 8.1x and solid profitability margins including 19.39% net income margin.
The stock presents a compelling value opportunity with analyst consensus price target of $53.50 representing 20% upside potential, though technical weakness and mixed analyst sentiment (33% buy, 60% hold) suggest near-term caution. Key risks include integration challenges from acquisitions and potential margin pressure from cost inflation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →